Prosecution Insights
Last updated: November 06, 2026
Application No. 18/538,696

MODULATING OBJECT SIGNATURES THROUGH THE USE OF PHOTOSENSTIVE SORBENT COATINGS

Non-Final OA §102§DOUBLEPATENT
Filed
Dec 13, 2023
Examiner
CHACKO DAVIS, DABORAH
Art Unit
1737
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Genesis Systems LLC
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
5m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
718 granted / 997 resolved
+7.0% vs TC avg
Strong +20% interview lift
Without
With
+20.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
36 currently pending
Career history
1055
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
36.0%
-4.0% vs TC avg
§102
28.6%
-11.4% vs TC avg
§112
25.2%
-14.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 997 resolved cases

Office Action

§102 §DOUBLEPATENT
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I claims 1-18, in the reply filed on August 11, 2026, is acknowledged. Newly submitted claims 25-26, are directed to an invention that is independent or distinct from the invention originally claimed for the following reasons: Claims 25-26, are directed to the using of a photosensitive coating, and claim 1 is a composition and is not limited to any particular process of using. Since applicant has received an action on the merits for the originally presented invention, this invention has been constructively elected by original presentation for prosecution on the merits. Accordingly, claims 25-26, are withdrawn from consideration as being directed to a non-elected invention. See 37 CFR 1.142(b) and MPEP § 821.03. To preserve a right to petition, the reply to this action must distinctly and specifically point out supposed errors in the restriction requirement. Otherwise, the election shall be treated as a final election without traverse. Traversal must be timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are subsequently added, applicant must indicate which of the subsequently added claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-3, 6-7, 9, 11-12, is/are rejected under 35 U.S.C. 102(a)(1)as being anticipated by U. S. Patent No. 5,389,496 (hereinafter referred to as Calvert). Calvert, in col 3, lines 45-68, and in col 4, discloses a coating of a substrate with a photosensitive material the coating includes metal, materials that comprise photoisomerizable ligating groups, precursors etc., wherein the precursor material enable ligand complexation via binding metals (claimed bridging ligand) (see col 7, lines 45-55), and in col 8, lines 1-47, Calvert discloses that the groups on the substrate that bind the metals (Ni or Pd) includes bipyridyl groups and bipyridine. Calvert, in col 7, lines 5-18, discloses that the groups present on the substrate includes photoisomerizable groups such as azobenzene and that thereby Calvert discloses coating a composition that comprises the same claimed components and possess the same claimed properties and include the components that undergo photoisomerization upon exposure, and in col 7, lines 18-29, Calvert, discloses that the transformations of the ligating groups present on the substrate such as azobenzene, occurs at the same claimed wavelengths (100-700nm) during exposure, and the exposure wavelengths include visible wavelengths, UV and X-ray i.e., Calvert’s photosensitive composition that comprises metal, ligands (bridging ligands) and photoisomerizable ligands such as azobenzene will inherently and necessarily transform in the claimed manner upon exposure to different wavelengths (claims 1-3, 6-7, 9, and 11-12). Claim(s) 1-3, 6-7, 9, and 11-18, is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by U. S. Patent Application Publication No. 2010/0221661 (hereinafter referred to as Bowles). Bowles, in the abstract, in [0005], [0125], [0126], discloses that the photosensitive coating composition includes metals, photochromic material such as spirobenzopyran, fulgides etc., (see [0071]-[0077]) that display activated and unactivated states (claimed open and closed phase) upon irradiation ([0012], 100nm-800nm wavelength) of the photosensitive material that constitute the photosensitive coating, and is the same claimed photosensitive ligand, and ligands that formed metal complexes such bipyridine (see [0068], claimed N-donor linker) and is the same claimed photosensitive composition that comprises the same claimed components. Bowles, in [0125], discloses that the metal can be ferromagnetic or paramagnetic and includes Fe and transition metals (that are paramagnetic) (claims 1-3, 6-7, 9, 11-12) Bowles, in [0052], discloses that the organic photochromic material in the photosensitive material composition undergoes activated and unactivated state and Bowles, in [0064], and [0071], discloses that the exposure of the composition to different wavelengths results in different responses i.e., at a first wavelength exposure the photochromic material in the photosensitive composition results in a first color, and upon exposure to a second wavelength the photosensitive composition displays a different color (second color) and is the same claimed photochemical transformation of two different states (claimed open and closed phase). Bowles, in [0052], discloses that the composition can demonstrate an activated and unactivated state based on the exposure wavelengths the composition was subjected to, and Bowles, in [0064], discloses that based on the irradiation wavelength a detectable response is generated in the photosensitive material such the wavelength emitted, or the wavelength of the radiation passing through the photosensitive material (radar or spectral signature), or the color displayed due to the irradiation or even the response to IR radiation ([0183]). Bowles, teaches in [0071], that photochromic material in the photosensitive coating is thermally reversible and are capable of switching from between a first and second state in response to actinic radiation and respond in the form of thermal energy (temperature profile, IR signature etc.) (claims 13-17). Bowles teaches the same claimed photosensitive composition and will inherently and necessarily possess the same claimed acoustic characteristics in its activated and unactivated (first and second state) (claim 18). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-18, are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-15 of U.S. Patent No. 12,629,654. Although the claims at issue are not identical, they are not patentably distinct from each other because claims 1-15 of U.S. Patent No. 12,629,654 fully encompasses claims 1-18 of the instant application. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Daborah Chacko-Davis whose telephone number is (571) 272-1380. The examiner can normally be reached on 9:30AM-6:00PM EST Mon-Fri. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sally A. Merkling can be reached on (571) 272-6297. The fax phone number for the organization where this application or proceeding is assigned is 571-272-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DABORAH CHACKO-DAVIS/Primary Examiner, Art Unit 1737 October 28, 2026.
Read full office action

Prosecution Timeline

Dec 13, 2023
Application Filed
Oct 30, 2026
Non-Final Rejection mailed — §102, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12772809
METHOD FOR FABRICATING MASK
4y 4m to grant Granted Oct 20, 2026
Patent 12769199
PHOTOMASK AND CORRECTING METHOD FOR EXPOSING APPARATUS USING PHOTOMASK
4y 2m to grant Granted Oct 20, 2026
Patent 12754479
EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION
3y 9m to grant Granted Oct 06, 2026
Patent 12736881
PROVIDING A BARRIER LAYER FOR PHOTORESIST PROCESSING
4y 1m to grant Granted Sep 15, 2026
Patent 12730374
PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME
3y 3m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
92%
With Interview (+20.4%)
3y 4m (~5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 997 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month